News
Bridging light and electrons
Published:15.01.24 — Researchers at EPFL and Max Planck have merged nonlinear optics with electron microscopy, unlocking new capabilities in material studies and the control of electron beams.
Oral peptides: A new era in drug development
Published:09.01.24 — Scientists at EPFL have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable diseases like certain types of cancer.
Laser additive manufacturing: listening for defects as they happen
Published:11.01.24 — Researchers from EPFL have resolved a long-standing debate surrounding laser additive manufacturing processes with a pioneering approach to defect detection.
Testing automated crack-detection methods for concrete
Published:10.01.24 — An EPFL Master’s student in civil engineering has evaluated the effectiveness of new computer-based methods for inspecting potentially dangerous cracks in concrete.
Methods for bypassing and treating spinal cord injury
Published:08.01.24 — Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed.
Supercharging CAR-T Cells for Cancer Treatment
Published:04.01.24 — Transformative research at EPFL introduces CAR-T cells that flourish in tumor environments, paving the way for unparalleled advancements in cancer immunotherapy.
Our top 10 news articles from 2023
Published:23.12.23 — We published nearly 300 news articles on EPFL’s homepage in 2023, detailing the latest developments in science, academics, student life, startups and EPFL in general.